Saint Novel Biotech Limited leverages cutting-edge artificial intelligence to revolutionize drug discovery. Our end-to-end platform reduces development time by up to 80% and cuts costs by 70% compared to traditional methods.
Comprehensive platform covering every stage of drug discovery, from target identification to clinical optimization
Exclusive Knowledgegraph derived from pharma experts with >60 years cumulative pharma experience. AI-powered identification and validation of novel drug targets using advanced machine learning algorithms.
Generative AI for creating novel molecules with optimal properties and high binding affinity.
Ultra-high throughput screening of compound libraries at unprecedented speed and accuracy.
AI-driven design of proteins, antibodies, and peptides for difficult-to-drug targets.
AI-guided autonomous laboratory for high-throughput synthesis and testing with exclusive access to humanized preclinical models.
AI-powered clinical trial design and patient stratification for higher success rates.
From initial concept to clinical candidate in record time
AI identifies novel, validated targets from our exclusive pharma knowledgegraph
1 monthGenerative AI designs molecules with optimal properties
2 monthsAI-guided optimization for potency and safety
2 monthsReady for IND submission and clinical trials
5 monthsAI-designed fusion proteins with proven efficacy in multiple solid tumor models
Ready to transform your drug discovery process? Get in touch with our team